For this purpose we assessed serum CCL21 in two large, well-characterized SSc cohorts by Luminex xMAP analysis, a high throughput, and timesaving method for the measurement of chemokines and biomarker in serum samples (33). This evidence concerns the gene CCL21 and systemic sclerosis.